Literature DB >> 18822470

The role of hyperuricemia and gout in kidney and cardiovascular disease.

N Lawrence Edwards1.   

Abstract

Elevated serum urate levels are recognized as leading to gouty arthritis, tophi formation, and uric acid kidney stones. While serum urate elevations have long been associated with renal disease, they are not usually considered to have a causal role in kidney dysfunction. However, recent epidemiologic studies have identified serum urate elevations as an independent risk factor for chronic kidney disease. Hyperuricemia has also been found to be an independent risk factor for cardiovascular disease and hypertension. An animal model of mild hyperuricemia has shed new light on a potential mechanism of microvascular changes leading to endothelial dysfunction, a precursor to both coronary artery disease and hypertension. Additional animal studies and recent epidemiologic findings have provided further evidence that soluble urate is a risk factor for nonarticular disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18822470     DOI: 10.3949/ccjm.75.suppl_5.s13

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  57 in total

1.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Authors:  Marian Goicoechea; Soledad García de Vinuesa; Ursula Verdalles; Caridad Ruiz-Caro; Jara Ampuero; Abraham Rincón; David Arroyo; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Effect of changes in renal circulation on serum uric acid levels in women with twin pregnancy.

Authors:  Miwa Igarashi; Hidehiko Miyake; Shunji Suzuki
Journal:  Clin Exp Nephrol       Date:  2010-06-17       Impact factor: 2.801

Review 3.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

Review 4.  Urate reduction and renal preservation: what is the evidence?

Authors:  Nicolas Macías; Marian Goicoechea; M S García de Vinuesa; Ursula Verdalles; Jose Luño
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

5.  Family history of exceptional longevity is associated with lower serum uric acid levels in Ashkenazi Jews.

Authors:  Jennifer Yi-Chun Lai; Gil Atzmon; Michal L Melamed; Thomas H Hostetter; Jill P Crandall; Nir Barzilai; Markus Bitzer
Journal:  J Am Geriatr Soc       Date:  2012-03-16       Impact factor: 5.562

Review 6.  Uric acid as a target of therapy in CKD.

Authors:  Diana I Jalal; Michel Chonchol; Wei Chen; Giovanni Targher
Journal:  Am J Kidney Dis       Date:  2012-10-09       Impact factor: 8.860

Review 7.  Hyperuricemia and cardiovascular risk.

Authors:  Davide Grassi; Giovambattista Desideri; Anna Vittoria Di Giacomantonio; Paolo Di Giosia; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-02-20

8.  Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules.

Authors:  Owen M Woodward; Deepali N Tukaye; Jinming Cui; Patrick Greenwell; Leeza M Constantoulakis; Benjamin S Parker; Anjana Rao; Michael Köttgen; Peter C Maloney; William B Guggino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

Review 9.  Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.

Authors:  Bruce N Cronstein; Prashanth Sunkureddi
Journal:  J Clin Rheumatol       Date:  2013-01       Impact factor: 3.517

Review 10.  Gout. Hyperuricemia and cardiovascular disease: how strong is the evidence for a causal link?

Authors:  Angelo L Gaffo; N Lawrence Edwards; Kenneth G Saag
Journal:  Arthritis Res Ther       Date:  2009-08-19       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.